Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

With other races on the horizon, she decided to go back on tirzepatide, the active ingredient in popular diabetes and weight-loss drugs Mounjaro and Zepbound. She had used it before to take off ...

Novo Nordisk sells semaglutide under the brands Wegovy and Ozempic for weight loss and type 2 diabetes treatment respectively. Image credit: Getty/UCG. A US judge has rejected efforts by a compounded ...

Mochi representatives did not respond to requests for comment. Lilly's complaint against Henry Meds alleges the telehealth company improperly referenced Lilly's approved drugs and clinical trials on ...

Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's weight loss drug Zepbound and its diabetes treatment Mounjaro, the company's latest attempt ...

The telemedicine entities Lilly are suing are Willow Health Services, Adonis Health (d/b/a Henry Meds), Mochi Health ... rival Novo Nordisk's (NVO) GLP-1, semaglutide, sold as Ozempic for diabetes ...

Mochi Health Corp, Fella Health and Delilah, Willow Health Services, and Henry ... the semaglutide shortage. Mochi can maintain these under personalised treatment plans because the medication ...

Lilly is suing Mochi Health, Henry Meds, Willow Health and Fella Health, claiming they are illegally selling compounded versions of tirzepatide. Lilly's suits argue that the knock-off tirzepatide ...